CryoCath/Endocare Deal Aimed At Minimally Invasive Cardiac Surgery Market
This article was originally published in The Gray Sheet
Executive Summary
CryoCath anticipates that its five-year exclusive global supply and market access agreement with Endocare will allow for the development of a cryoablation device that can be used in keyhole surgery.